Sociedad Argentina de Hematología

 

 

 

 

 

 

 

 

 

 

 

ISSN 2250-8309

 

Formulario de cesión
de Derechos de Autor

Se solicita enviar el siguiente formulario, debidamente firmado por todos los autores del trabajo presentado

por Fax (11) 48552452

o personalmente en la SAH
o en archivo PDF por mail

Formulario de Cesión de Derechos de Autor

 

 

  REVISTA ARGENTINA DE HEMATOLOGÍA                                                                                    « Back »

Volumen:    21    # Number : 2

Publication Date :    MAYO - AGOSTO    Year:    2017

   ARTÍCULO ORIGINAL

Changes in the epidemiology of invasive fungal infections and impact of primary prophylaxis with voriconazole in a pediatric cohort of bone marrow trasplants recipients
Authors: Juliá A1, Figueroa Turienzo CM1, Roizen M1, Epelbaum C, Santos P, Staciuk, R

Abstract: Introduction: invasive fungal infections (IFI) are an important cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). At the end of 2013, due to an increase in IFI by FF, our hospital decided to change antifungal primary prophylaxis with fluconazole for voriconazole during neutropenia up to 100 days after HSCT. Objective: to analyse effects of the change of antifungal primary prophylaxis in a retrospective cohort of recipients of HSCT. Materials and methods: we performed a retrospective analysis of all patients, who underwent HSCT at Hospital Garrahan between 2012-2013 (P1) and 2014- 2015 (P2); we analyzed patients that showed IFI. Results: frequency of IFI, transplant related mortality (TRM), and direct mortality due to IFI (DMIFI) in recipients of HSCT with antifungal primary prophylaxis. IFI: P1, 21/55 (38,1%) vs. P2 6/47 (12,7%) p 0,047. IFI due to yeasts: P1 9/55 (16,3%) vs. P2 3/47 (6,3%). IFI due to FF: P1 12/55 (21,8%) vs. P2 3/47 (6,3%) p 0,047. TRM: P1 21/55 (38,1%) vs. P2 7/47 (14,8%) p <0,01. DMIFI: P1 5/55 (9%) vs. P2 0/47 (0%) Conclusion: primary prophylaxis with voriconazole was associated with a decrease in IFI due to HF FF and DMIFI. There was also a decrease in TRM between both periods. The risk of mucormycosis emergency requires strict epidemiological follow-up.

Key words: Invasive fungal infections, HSCT, Antifungal primary prophylaxis.

Pages :

  Resumen             pdf  

SOCIEDAD ARGENTINA DE HEMATOLOGÍA
Julián Alvarez 146 - Ciudad Autónoma de Bs As - Argentina
(54-11) 4855-2452 / 2485

http://www.sah.org.ar/revista/